Overall Technical outlook

Price Summary

On 2025-08-13, Aurobindo Pharma Limited's stock began at 1059.2, peaked at 1083.6, declined to 1057.2, and ended the day 1.79% higher at 1078.2, with 444368 shares traded.
The peak price for the stock in the past 52 weeks is 1569.4, with the lowest price being 1042.1.
28 analysts forecast that the price of AUROPHARMA will range from 730.0 to 1930.0, with an average expected price near 1293.3928.

Technicals

Support and Resistance: The price for AUROPHARMA at 1078.2 finds support at 1051.75 and resistance at 1114.5. This suggests a trading range, where 1051.75 serves as a support level and 1114.5 acts as a resistance point, potentially capping further gains.
AUROPHARMA supportResistance 4d227d
Support/Resistance for AUROPHARMA


Aroon: The AROON is showing a neutral stance, not indicating a clear upward or downward trend for Aurobindo Pharma Limited. This suggests a period of market balance, where neither side is showing dominance.
AUROPHARMA aroon 4d227d
Aroon chart for Aurobindo Pharma Limited


Bol. Bands: The current reading of the BOLL BANDS is neutral for AUROPHARMA, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
AUROPHARMA bbands 4d227d
Bolinger Bands chart for Aurobindo Pharma Limited


Parabolic SAR: The PSAR remains bearish for Aurobindo Pharma Limited, establishing a crucial resistance level that could hinder any bullish attempts. This ongoing bearish outlook suggests that the market may continue to face resistance, making it difficult for prices to rise.
AUROPHARMA psar 4d227d
Parabolic Stop and Reverse chart for Aurobindo Pharma Limited


Stochastic: The current state of the STOCHASTIC is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
AUROPHARMA stoch 4d227d
Stochastic chart for Aurobindo Pharma Limited


Tripple Moving Agerage: The moving averages for the 20-50-100 periods indicate a bullish trend, though the slopes of the faster averages suggest that this trend may not last. The weakening signals from the shorter-term averages point to a potential reversal, indicating that the current upward momentum could be approaching a turning point.
AUROPHARMA trippleSMA 4d227d
Tripple SMA chart for Aurobindo Pharma Limited


Analyzing the technical indicators of a company, such as stock price and trading volume, requires first understanding its fundamentals. These fundamentals include profitability, growth potential, and market position. Furthermore, knowing the broader industry trends and competitive landscape provides critical context. When both the company's internal data and the external environment are considered, it allows for more meaningful conclusions about the company's technical performance and future trajectory.